HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 206 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $16,975,635 | +26.8% | 324,209 | -1.5% | 0.02% | +20.0% |
| Q1 2024 | $13,388,674 | -24.7% | 329,123 | -31.5% | 0.02% | -31.0% |
| Q4 2023 | $17,770,180 | -11.9% | 480,796 | -9.0% | 0.03% | -19.4% |
| Q3 2023 | $20,173,468 | +42.0% | 528,100 | +34.0% | 0.04% | +44.0% |
| Q2 2023 | $14,210,456 | -9.1% | 393,971 | -3.8% | 0.02% | -13.8% |
| Q1 2023 | $15,633,271 | -25.3% | 409,355 | +11.3% | 0.03% | -38.3% |
| Q4 2022 | $20,926,538 | +26.4% | 367,777 | -12.2% | 0.05% | +27.0% |
| Q3 2022 | $16,553,000 | -4.3% | 418,646 | +6.5% | 0.04% | 0.0% |
| Q2 2022 | $17,299,000 | +5.5% | 393,017 | -4.2% | 0.04% | +12.1% |
| Q1 2022 | $16,393,000 | -8.2% | 410,171 | -7.5% | 0.03% | 0.0% |
| Q4 2021 | $17,856,000 | +17.3% | 443,653 | +18.6% | 0.03% | +3.1% |
| Q3 2021 | $15,226,000 | -13.7% | 374,138 | -3.7% | 0.03% | -17.9% |
| Q2 2021 | $17,635,000 | +3.7% | 388,402 | -4.8% | 0.04% | -9.3% |
| Q1 2021 | $17,005,000 | +29.6% | 408,111 | +32.6% | 0.04% | +26.5% |
| Q4 2020 | $13,117,000 | -6.3% | 307,840 | -42.3% | 0.03% | -17.1% |
| Q3 2020 | $14,000,000 | -4.5% | 533,490 | -2.6% | 0.04% | -10.9% |
| Q2 2020 | $14,664,000 | +63.7% | 547,933 | +9.7% | 0.05% | +39.4% |
| Q1 2020 | $8,959,000 | +443.0% | 499,466 | +435.2% | 0.03% | +560.0% |
| Q4 2019 | $1,650,000 | -27.5% | 93,330 | -36.4% | 0.01% | -16.7% |
| Q3 2019 | $2,277,000 | +0.9% | 146,791 | +11.8% | 0.01% | -14.3% |
| Q2 2019 | $2,257,000 | -8.7% | 131,350 | -14.5% | 0.01% | -12.5% |
| Q1 2019 | $2,473,000 | -63.8% | 153,595 | -59.2% | 0.01% | -66.7% |
| Q4 2018 | $6,838,000 | 0.0% | 376,339 | 0.0% | 0.02% | -4.0% |
| Q3 2018 | $6,838,000 | +20.8% | 376,339 | +12.1% | 0.02% | +31.6% |
| Q2 2018 | $5,662,000 | -10.8% | 335,624 | +3.6% | 0.02% | -20.8% |
| Q1 2018 | $6,348,000 | +1.4% | 324,044 | +4.8% | 0.02% | +9.1% |
| Q4 2017 | $6,261,000 | +11.8% | 309,057 | -4.1% | 0.02% | +10.0% |
| Q3 2017 | $5,598,000 | +30.3% | 322,262 | -3.8% | 0.02% | +17.6% |
| Q2 2017 | $4,295,000 | +7.0% | 335,025 | +8.2% | 0.02% | -5.6% |
| Q1 2017 | $4,014,000 | +32.3% | 309,725 | +0.8% | 0.02% | +20.0% |
| Q4 2016 | $3,034,000 | -3.0% | 307,120 | +18.6% | 0.02% | -6.2% |
| Q3 2016 | $3,127,000 | +62.3% | 258,885 | +15.9% | 0.02% | +33.3% |
| Q2 2016 | $1,927,000 | -7.0% | 223,280 | +2.1% | 0.01% | -7.7% |
| Q1 2016 | $2,072,000 | -44.0% | 218,765 | +2.5% | 0.01% | -43.5% |
| Q4 2015 | $3,697,000 | +15.5% | 213,345 | -10.5% | 0.02% | -20.7% |
| Q3 2015 | $3,202,000 | +35.4% | 238,391 | +127.7% | 0.03% | +38.1% |
| Q2 2015 | $2,364,000 | +161.8% | 104,673 | +65.6% | 0.02% | +162.5% |
| Q1 2015 | $903,000 | – | 63,213 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $195,784,000 | 9.33% |
| BB BIOTECH AG | 5,846,564 | $57,764,000 | 2.74% |
| QVT Financial LP | 4,556,090 | $45,014,000 | 2.44% |
| Parametrica Management Ltd | 29,578 | $292,000 | 2.21% |
| SECTORAL ASSET MANAGEMENT INC | 4,389,682 | $43,370,000 | 1.84% |
| Belmont Global Advisors, Inc. | 257,000 | $2,539,000 | 1.83% |
| HARVEY CAPITAL MANAGEMENT INC | 394,550 | $3,898,000 | 1.40% |
| Lombard Odier Asset Management (USA) Corp | 1,350,000 | $13,338,000 | 0.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,199,685 | $61,253,000 | 0.63% |
| Callan Capital, LLC | 199,230 | $1,968,000 | 0.53% |